Adherence to Chronic Hepatitis B Treatment Guideline Recommendations for Laboratory Monitoring of Patients Who Are Not Receiving Antiviral Treatment

Por Juday, Timothy, Tang, Hong, Harris, Melissa, Powers, Annette Z., Kim, Edward, Hanna, George J.
Publicado em 2010

Activity of the HIV-1 Attachment Inhibitor BMS-626529, the Active Component of the Prodrug BMS-663068, against CD4-Independent Viruses and HIV-1 Envelopes Resistant to Other Entry...

Por Li, Zhufang, Zhou, Nannan, Sun, Yongnian, Ray, Neelanjana, Lataillade, Max, Hanna, George J., Krystal, Mark
Publicado em 2013

Predictive Genotypic Algorithm for Virologic Response to Lopinavir-Ritonavir in Protease Inhibitor-Experienced Patients

Por King, Martin S., Rode, Richard, Cohen-Codar, Isabelle, Calvez, Vincent, Marcelin, Anne-Geneviève, Hanna, George J., Kempf, Dale J.
Publicado em 2007

Predictive Genotypic Algorithm for Virologic Response to Lopinavir-Ritonavir in Protease Inhibitor-Experienced Patients

Por King, Martin S., Rode, Richard, Cohen-Codar, Isabelle, Calvez, Vincent, Marcelin, Anne-Geneviève, Hanna, George J., Kempf, Dale J.
Publicado em 2008

Pharmacokinetic Interactions between BMS-626529, the Active Moiety of the HIV-1 Attachment Inhibitor Prodrug BMS-663068, and Ritonavir or Ritonavir-Boosted Atazanavir in Healthy Su...

Por Zhu, Li, Hruska, Matthew, Hwang, Carey, Shah, Vaishali, Furlong, Michael, Hanna, George J., Bertz, Richard, Savant Landry, Ishani
Publicado no Antimicrob Agents Chemother (2015)

Comparison of Sequencing by Hybridization and Cycle Sequencing for Genotyping of Human Immunodeficiency Virus Type 1 Reverse Transcriptase

Por Hanna, George J., Johnson, Victoria A., Kuritzkes, Daniel R., Richman, Douglas D., Martinez-Picado, Javier, Sutton, Lorraine, Hazelwood, J. Darren, D'Aquila, Richard T.
Publicado em 2000

In Vitro Selection and Characterization of Human Immunodeficiency Virus Type 2 with Decreased Susceptibility to Lopinavir

Por Masse, Sherie, Lu, Xiaozhi, Dekhtyar, Tatyana, Lu, Liangjun, Koev, Gennadiy, Gao, Feng, Mo, Hongmei, Kempf, Dale, Bernstein, Barry, Hanna, George J., Molla, Akhteruzzaman
Publicado em 2007

Antiviral Activity, Pharmacokinetics, and Safety of BMS-488043, a Novel Oral Small-Molecule HIV-1 Attachment Inhibitor, in HIV-1-Infected Subjects

Por Hanna, George J., Lalezari, Jacob, Hellinger, James A., Wohl, David A., Nettles, Richard, Persson, Anna, Krystal, Mark, Lin, Pinfang, Colonno, Richard, Grasela, Dennis M.
Publicado em 2011

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

Por Palmer, Sarah, Maldarelli, Frank, Wiegand, Ann, Bernstein, Barry, Hanna, George J., Brun, Scott C., Kempf, Dale J., Mellors, John W., Coffin, John M., King, Martin S.
Publicado em 2008

Safety profile of HIV-1 attachment inhibitor prodrug BMS-663068 in antiretroviral-experienced subjects: week 24 analysis

Por Lalezari, Jacob, Latiff, Gulam H, Brinson, Cynthia, Echevarria, Juan, Treviño-Pérez, Sandra, Bogner, Johannes R, Stock, David, Joshi, Samit R, Hanna, George J, Lataillade, Max
Publicado no J Int AIDS Soc (2014)

Model-Based Phase 3 Dose Selection for HIV-1 Attachment Inhibitor Prodrug BMS-663068 in HIV-1-Infected Patients: Population Pharmacokinetics/Pharmacodynamics of the Active Moiety,...

Por Landry, Ishani, Zhu, Li, Abu Tarif, Malaz, Hruska, Matthew, Sadler, Brian M., Pitsiu, Maria, Joshi, Samit, Hanna, George J., Lataillade, Max, Boulton, David W., Bertz, Richard J.
Publicado no Antimicrob Agents Chemother (2016)

In Vitro Cross-Resistance Profile of Nucleoside Reverse Transcriptase Inhibitor (NRTI) BMS-986001 against Known NRTI Resistance Mutations

Por Li, Zhufang, Terry, Brian, Olds, William, Protack, Tricia, Deminie, Carol, Minassian, Beatrice, Nowicka-Sans, Beata, Sun, Yongnian, Dicker, Ira, Hwang, Carey, Lataillade, Max, Hanna, George J., Krystal, Mark
Publicado em 2013

In Vivo Patterns of Resistance to the HIV Attachment Inhibitor BMS-488043

Por Zhou, Nannan, Nowicka-Sans, Beata, Zhang, Sharon, Fan, Li, Fang, Jie, Fang, Hua, Gong, Yi-Fei, Eggers, Betsy, Langley, David R., Wang, Tao, Kadow, John, Grasela, Dennis, Hanna, George J., Alexander, Louis, Colonno, Richard, Krystal, Mark, Lin, Pin-Fang
Publicado em 2011

ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia

Por Maldarelli, Frank, Palmer, Sarah, King, Martin S, Wiegand, Ann, Polis, Michael A, Mican, JoAnn, Kovacs, Joseph A, Davey, Richard T, Rock-Kress, Diane, Dewar, Robin, Liu, Shuying, Metcalf, Julia A, Rehm, Catherine, Brun, Scott C, Hanna, George J, Kempf, Dale J, Coffin, John M, Mellors, John W
Publicado em 2007

In Vitro Antiviral Characteristics of HIV-1 Attachment Inhibitor BMS-626529, the Active Component of the Prodrug BMS-663068

Por Nowicka-Sans, Beata, Gong, Yi-Fei, McAuliffe, Brian, Dicker, Ira, Ho, Hsu-Tso, Zhou, Nannan, Eggers, Betsy, Lin, Pin-Fang, Ray, Neelanjana, Wind-Rotolo, Megan, Zhu, Li, Majumdar, Antara, Stock, David, Lataillade, Max, Hanna, George J., Matiskella, John D., Ueda, Yasutsugu, Wang, Tao, Kadow, John F., Meanwell, Nicholas A., Krystal, Mark
Publicado em 2012